newsfilter
← Earnings
Earnings Releases·

Xtant Medical — Third Quarter 2026 Earnings Summary

Xtant Medical Holdings reported third-quarter 2026 total revenue of $24.3 million, a decrease from $33.3 million in the same period of 2025, primarily due to the absence of revenue from divested businesses and wound care licensing. The company posted a net loss of $3.6 million for the quarter, while biologics revenue grew 13% year-over-year to $19.3 million. The Board of Directors has initiated a strategic review to evaluate various operational and financial alternatives aimed at maximizing stockholder value. Consequently, the company has withdrawn its full-year 2026 financial guidance and will not host a conference call to discuss these results.

Company
XTANT MEDICAL HOLDINGS INC
Sector
Healthcare
Industry
Medical Devices